… demonstrated manageable safety and early signs of anti-tumor activity in patients with relapsed small cell lung … a humanized anti-DLL3 IgG1 monoclonal antibody linked to a DNA topoisomerase I inhibitor via a cleavable linker. Given …

… laboratory projects focus on the clonal evolution of tumors, cell-free plasma DNA as biomarkers for early detection, and the role of …

… biology and its evolution over time, using tools like circulating tumour DNA from liquid biopsies, to match patients to the adjuvant … a targeted therapy,” she stated. “The possibility to study circulating tumour cells from blood samples has been a …

… Award to Gabriella Sozzi, PhD. Dr. Sozzi leads the Tumor Genomics Unit at Fondazione IRCCS Istituto Nazionale Tumori (INT) in Milan, Italy. She graduated in Biological … of lung cancer in screening programs. In the field of circulating biomarkers, she has a demonstrated record of …